tirzepatide for type 2 diabetes (Mounjaro): A Dual-Action Breakthrough and Weight Loss What Is Tirzepatide? How It

MICHELLE: It's the voices in my head

#obesity #glp1 #healthcareinnovation #healthcaredata To view or add a comment, sign in More Relevant Posts Large Study of Medicare Patients with DFUs Reveals Benefits of DHACM in Reducing Amputations and Long-Term Health-Care Costs To view or add a comment, sign in A Life-Saving Opportunity for Communities Like 78207 New analysis shows that expanding Medicaid coverage for GLP-1 drugs (like Ozempic and Wegovy) across all states could save countless livesand may be far more affordable than we think

Route 2 employs the 40-3 side chain, which is the deprotected version of 15-9

Key Takeaway: Semaglutide targets one hormone pathway (GLP-1), while Zepbound targets two (GLP-1 and GIP)